GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
8d
Medpage Today on MSNUse of GLP-1 Drugs for Obesity Linked to Lower Risk of GlaucomaUse of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...
Objective: To review drug interaction studies of glucagon-like peptide-1 ... action. Studies in patients with type 2 diabetes are needed to further assess and allow comparison of several GLP ...
Working with a weight management program can help sustain the use of GLP-1 therapies and address potential side effects. Patient education and expectation management are crucial for maximizing ...
The first reason is because the mechanism of action [MOA] of using a GLP-1 Receptor ... short amount of 12-weeks already proved that its GLP-1 RA MET-097i already attained a mean placebo adjusted ...
or it had a different mechanism of action. “There’s a lot of hype and excitement around GLP-1 and like medications,” Youssef. “And the thing I want to see is long-term safety data.
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
Adults aged 66 years or older with T2D initiating treatment with a GLP-1 RA were propensity score-matched to those initiating treatment with an SGLT-2i (14,665 matched pairs) or a DPP-4i (13,711 ...
Share on Pinterest Scientists have found a protein that may aid GLP-1 users in maintaining their ... Further experiments revealed the mechanism at work. Fasting triggers the release of growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results